Integrins as attractive targets for cancer therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Integrins as attractive targets for cancer therapeutics

Published:2021-09 Issue:9 Volume:11 Page:2726-2737
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Li Meng,Wang Ying,Li Mengwei,Wu Xuezhen,Setrerrahmane Sarra,Xu Hanmei

Funder

National Major Science and Technology Projects of China

National Institutes for Food and Drug Control

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference158 articles.

1. Integrin trafficking in cells and tissues;Moreno-Layseca;Nat Cell Biol,2019

2. Integrin ligands at a glance;Humphries;J Cell Sci,2006

3. Integrin signalling during tumour progression;Guo;Nat Rev Mol Cell Biol,2004

4. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways;Han;Cancer Res,2006

5. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer;Vellon;Oncogene,2005

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of ABLIM3 confers to the metastasis of neuroblastoma via regulating the cell adhesion molecules pathway;Computational and Structural Biotechnology Journal;2024-12

2. A novel selective FAK inhibitor E2 inhibits ovarian cancer metastasis and growth by inducing cytotoxic autophagy;Biochemical Pharmacology;2024-11

3. Unraveling the molecular basis for effective regulation of integrin α5β1 for enhanced therapeutic interventions;Biochemical and Biophysical Research Communications;2024-11

4. Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review;Bioorganic & Medicinal Chemistry;2024-09

5. Molecular Insights into Hybrid Tumors: Exploring the Heterogeneity in Plexiform Ameloblastoma;Seminars in Diagnostic Pathology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3